Tharimmune, Inc.

New Filing
CIK: 0001861657·Biotechnology·DELAWARE·Filed: Jun 28, 2024
Total Offering

$2,084,160

Amount Sold

$2,084,160

Investors

5

First Sale

Jun 18, 2024

Offering Details

Type
Equity, Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Randy Milby
Related Person
Sireesh Appajosyula
Related Person
Leonard Mazur
Related Person
Kelly Anderson
Related Person
Lynne A/ Bui
Related Person
Thomas Hess
Related Person

Company

Canton Strategic Holdings, Inc.

1200 ROUTE 22 EAST

BRIDGEWATER, NJ, 08807

(908) 955-3140

SEC Filing

0001493152-24-025662

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Tharimmune, Inc. Form D Filing — $2,084,160 | FilingFlow